Abstract:A study of the pathways responsible for the synthesis of two natural products — curacin and jamaicamide — in the cyanobacterium Lyngbya majuscula reveals two biosynthetic pathways with high sequence identity. Yet they are responsible for the production of two dramatically different chemical motifs: a β-branched cyclopropane in the curacin A pathway, and a vinyl chloride group in the jamaicamide pathway. The biochemical characterization of several domains of the biosynthetic pathways, including the halogenase domains and the enoyl reductase domains, reveals details of the mechanisms by which the cyclopropane and vinyl chloride groups are generated. Co-evolution of enzymes for metabolic diversification is not well understood, especially at the biochemical level. Here, the biosynthetic pathways responsible for the synthesis of two natural products, curacin and jamaicamide, are examined; several domains are characterized to help determine how, although the two pathways have a high sequence identity, they are responsible for the production of two such dramatically different chemical motifs. Natural product chemical diversity is fuelled by the emergence and ongoing evolution of biosynthetic pathways in secondary metabolism1. However, co-evolution of enzymes for metabolic diversification is not well understood, especially at the biochemical level. Here, two parallel assemblies with an extraordinarily high sequence identity from Lyngbya majuscula form a β-branched cyclopropane in the curacin A pathway (Cur), and a vinyl chloride group in the jamaicamide pathway (Jam). The components include a halogenase, a 3-hydroxy-3-methylglutaryl enzyme cassette for polyketide β-branching, and an enoyl reductase domain. The halogenase from CurA, and the dehydratases (ECH1s), decarboxylases (ECH2s) and enoyl reductase domains from both Cur and Jam, were assessed biochemically to determine the mechanisms of cyclopropane and vinyl chloride formation. Unexpectedly, the polyketide β-branching pathway was modified by introduction of a γ-chlorination step on (S)-3-hydroxy-3-methylglutaryl mediated by Cur halogenase, a non-haem Fe(ii), α-ketoglutarate-dependent enzyme2. In a divergent scheme, Cur ECH2 was found to catalyse formation of the α,β enoyl thioester, whereas Jam ECH2 formed a vinyl chloride moiety by selectively generating the corresponding β,γ enoyl thioester of the 3-methyl-4-chloroglutaconyl decarboxylation product. Finally, the enoyl reductase domain of CurF specifically catalysed an unprecedented cyclopropanation on the chlorinated product of Cur ECH2 instead of the canonical α,β C = C saturation reaction. Thus, the combination of chlorination and polyketide β-branching, coupled with mechanistic diversification of ECH2 and enoyl reductase, leads to the formation of cyclopropane and vinyl chloride moieties. These results reveal a parallel interplay of evolutionary events in multienzyme systems leading to functional group diversity in secondary metabolites.

Antibiotic Skeletal Diversification via Differential Enoylreductase Recruitment and Module Iteration in trans -Acyltransferase Polyketide Synthases

Biosynthesis and Genetic Engineering of Polyketides

Evolution-guided engineering of trans -acyltransferase polyketide synthases

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Reconstitution of the FK228 biosynthetic pathway reveals cross talk between modular polyketide synthases and fatty acid synthase

Natural diversifying evolution of nonribosomal peptide synthetases in a defensive symbiont reveals nonmodular functional constraints

Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.

Metamorphic Enzyme Assembly in Polyketide Diversification.

Evolution-inspired engineering of nonribosomal peptide synthetases

Exploiting the inherent promiscuity of the acyl transferase of the stambomycin polyketide synthase for the mutasynthesis of analogues

Engineering from evolution

Challenging old microbiological treasures for natural compound biosynthesis capacity

Functional Analysis of Regulatory Components for Antibiotic Biosynthesis

Directed evolution of the nonribosomal peptide synthetase AdmK generates new andrimid derivatives in vivo

Engineered biosynthesis of natural products in heterologous hosts.

Biosynthesis-based artificial evolution of microbial natural products

Overcoming Antibiotic Resistance Through Efficient and Scalable Total Synthesis

Intrinsic and Extrinsic Programming of Product Chain Length and Release Mode in Fungal Collaborating Iterative Polyketide Synthases

Expanding the substrate selectivity of the fimsbactin biosynthetic adenylation domain, FbsH

Streptomyces: The biofactory of secondary metabolites

Targeted discovery of polyketides with antioxidant activity through integrated omics and cocultivation strategies